<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="oil1000/PMC6358877/results/search/disease/results.xml">
  <result pre="toxicity and cost, these compounds forms an integral part of" exact="cancer" post="research and is well established as a potential anticancer"/>
  <result pre="(IARC) has estimated that, by 2030, about 21.7 million recently-developed" exact="cancer" post="cases and about 13 million cancer-related deaths would result"/>
  <result pre="turmeric elucidate their imperative role in reducing the mortality by" exact="cancer" post="[ 5, 6, 7]. Turmeric ( Curcuma longa L.),"/>
  <result pre="107, 108, 109, 110] ( Table 2). Depending on different" exact="cancer" post="cell lines there are various anticancer pathways enrolled in"/>
  <result pre="Further, this study explained that turmerones restrain the proliferation of" exact="cancer" post="cells in a dose-dependent manner with half maximal inhibitory"/>
  <result pre="promising anticancer agent with distinct mechanism of action for different" exact="cancer" post="cell lines. In this series, Lee et al. reported"/>
  <result pre="ar-turmerone could bring DNA fragmentation (apoptosis) in human chronic myelogenous" exact="leukemia" post="(K562), rat baselophilic leukemia (RBL-2H3), human histiocytic lymphoma (U937),"/>
  <result pre="fragmentation (apoptosis) in human chronic myelogenous leukemia (K562), rat baselophilic" exact="leukemia" post="(RBL-2H3), human histiocytic lymphoma (U937), and mouse lymphocytic leukemia"/>
  <result pre="chronic myelogenous leukemia (K562), rat baselophilic leukemia (RBL-2H3), human histiocytic" exact="lymphoma" post="(U937), and mouse lymphocytic leukemia (L1210) in a dose-"/>
  <result pre="baselophilic leukemia (RBL-2H3), human histiocytic lymphoma (U937), and mouse lymphocytic" exact="leukemia" post="(L1210) in a dose- and time-dependent manner [ 34]."/>
  <result pre="protein gene 1 (MDR1), multi-resistance protein gene 2 (MDR2), and" exact="breast cancer" post="resistance protein (BCRP). This was observed by the levels"/>
  <result pre="gene 1 (MDR1), multi-resistance protein gene 2 (MDR2), and breast" exact="cancer" post="resistance protein (BCRP). This was observed by the levels"/>
  <result pre="and ar-turmerone have promising potential as anticancer drugs in multi-resistant" exact="cancer" post="cells and colorectal cancer, respectively [ 35]. Further, ar-turmerone"/>
  <result pre="promising potential as anticancer drugs in multi-resistant cancer cells and" exact="colorectal cancer," post="respectively [ 35]. Further, ar-turmerone was reported to efficiently"/>
  <result pre="formation, migration, stimulated matrix metalloproteinase (MMP-9), and cyclooxygenase-2 (COX-2) in" exact="breast cancer" post="cells at non-cytotoxic concentrations. In addition, suppression noticed in"/>
  <result pre="migration, stimulated matrix metalloproteinase (MMP-9), and cyclooxygenase-2 (COX-2) in breast" exact="cancer" post="cells at non-cytotoxic concentrations. In addition, suppression noticed in"/>
  <result pre="(COX-2) in breast cancer cells at non-cytotoxic concentrations. In addition," exact="suppression" post="noticed in MMP-9 and COX-2 promoter activation was due"/>
  <result pre="kinase B (PI3K/Akt) and extracellular regulated kinase (ERK)1/2 signaling in" exact="breast cancer" post="cells [ 36]. Other researchers, Yong-gang et al., examined"/>
  <result pre="B (PI3K/Akt) and extracellular regulated kinase (ERK)1/2 signaling in breast" exact="cancer" post="cells [ 36]. Other researchers, Yong-gang et al., examined"/>
  <result pre="isothiocyanate-dextran (FITC-dextran) bioassay for evaluating the effects of ar-turmerone on" exact="breast cancer" post="cells. These tests showed that ar-turmerone increased the expression"/>
  <result pre="(FITC-dextran) bioassay for evaluating the effects of ar-turmerone on breast" exact="cancer" post="cells. These tests showed that ar-turmerone increased the expression"/>
  <result pre="the intrinsic apoptotic pathway was provoked by decreasing B cell" exact="lymphoma" post="(Bcl)-2 and Bcl-xL and increasing PUMA and Bax with"/>
  <result pre="activities were enhanced in combination with turmerones in human colonic" exact="cancer" post="cells (HCT–116, HT–29) and human umbilical vein endothelial cells"/>
  <result pre="showed more potency than cisplatin kept as control over human" exact="leukemia" post="cells (K562) and human lung cancer cells (A549) ["/>
  <result pre="kept as control over human leukemia cells (K562) and human" exact="lung cancer" post="cells (A549) [ 41]. Even, if significant changes were"/>
  <result pre="as control over human leukemia cells (K562) and human lung" exact="cancer" post="cells (A549) [ 41]. Even, if significant changes were"/>
  <result pre="a decrease in effective dose-50% value (ED 50) against lymphocytic" exact="leukemia" post="(L1210) cell study [ 42]. Baik et al. further"/>
  <result pre="changes in morphological characters in ar-turmerone triggered apoptosis in human" exact="myeloid leukemia" post="HL-60 cells in a concentration-dependent manner, as it produced"/>
  <result pre="in morphological characters in ar-turmerone triggered apoptosis in human myeloid" exact="leukemia" post="HL-60 cells in a concentration-dependent manner, as it produced"/>
  <result pre="administration and is extensively used in the chemotherapy of the" exact="cancer" post="patients in China. Many investigations have led to the"/>
  <result pre="sesquiterpene which is studied for its anticancer activity in various" exact="cancer" post="cells through its antiproliferative activity with subsequent induction of"/>
  <result pre="a range of studies dealing with their effects on different" exact="cancer" post="cell lines, mainly on non-small cell lung cancer (NSCLC)"/>
  <result pre="effects on different cancer cell lines, mainly on non-small cell" exact="lung cancer" post="(NSCLC) cells and the effective mode of action to"/>
  <result pre="on different cancer cell lines, mainly on non-small cell lung" exact="cancer" post="(NSCLC) cells and the effective mode of action to"/>
  <result pre="the mitochondrial release of the cytochrome c-mediated apoptotic pathway. These" exact="lung cancer" post="cells were arrested at the G2-M phase, which caused"/>
  <result pre="mitochondrial release of the cytochrome c-mediated apoptotic pathway. These lung" exact="cancer" post="cells were arrested at the G2-M phase, which caused"/>
  <result pre="proved to be a promising regimen for the treatment of" exact="lung cancer" post="and cisplatin-resistant tumors [ 49] ( Figure 3B). Further,"/>
  <result pre="to be a promising regimen for the treatment of lung" exact="cancer" post="and cisplatin-resistant tumors [ 49] ( Figure 3B). Further,"/>
  <result pre="Figure 3B). Further, investigation of β-elemene on human non-small cell" exact="lung cancer" post="A549 cells by Shu et al. explained that β-elemene"/>
  <result pre="3B). Further, investigation of β-elemene on human non-small cell lung" exact="cancer" post="A549 cells by Shu et al. explained that β-elemene"/>
  <result pre="of ERK and Akt activation and upregulation of Casitas B–lineage" exact="lymphoma" post="(c-Cb1 and Cb1-b) expression, which enhanced apoptosis in a"/>
  <result pre="Cb1-b) expression, which enhanced apoptosis in a dose-dependent manner in" exact="lung cancer" post="cells (A549) [ 51]. Furthermore, the intensive antiproliferative effect"/>
  <result pre="expression, which enhanced apoptosis in a dose-dependent manner in lung" exact="cancer" post="cells (A549) [ 51]. Furthermore, the intensive antiproliferative effect"/>
  <result pre="C. aromatica and combined with etoposide, proved very beneficial for" exact="lung cancer" post="[ 53]. β-elemene has a promising therapeutic role in"/>
  <result pre="aromatica and combined with etoposide, proved very beneficial for lung" exact="cancer" post="[ 53]. β-elemene has a promising therapeutic role in"/>
  <result pre="a promising therapeutic role in human SGC7901 and MKN45 gastric" exact="cancer" post="cells. β-elemene inhibited the cell viability and clonogenic survival"/>
  <result pre="β-elemene inhibited the cell viability and clonogenic survival of gastric" exact="cancer" post="cell that were decreased in a dose-dependent manner, with"/>
  <result pre="reaction (RT-PCR) confirmed the presence of c-Met expression in H22" exact="hepatocellular carcinoma" post="xenograft model in vitro and in vivo. The test"/>
  <result pre="results showed that the induction of growth inhibition in murine" exact="hepatocellular carcinoma" post="cells by β-elemene was brought about by downregulation of"/>
  <result pre="when treated on SGC7901/ADR cells. Thus, β-elemene could target gastric" exact="cancer" post="cells and p-gp overexpressing leukemia to increase the efficacy"/>
  <result pre="Thus, β-elemene could target gastric cancer cells and p-gp overexpressing" exact="leukemia" post="to increase the efficacy of doxorubicin treatment [ 58]."/>
  <result pre="protein kinase 3/6/p38 and extracellular signal regulated kinase 1/2/B cell" exact="lymphoma" post="2/surviving pathways, inhibition of cell proliferation was facilitated and"/>
  <result pre="cancerous cells. In the same way, it partially reverses Adriamycin-resistant" exact="breast cancer" post="cells (MCF-7/ADM) [ 12]. Moreover, there were many studies"/>
  <result pre="cells. In the same way, it partially reverses Adriamycin-resistant breast" exact="cancer" post="cells (MCF-7/ADM) [ 12]. Moreover, there were many studies"/>
  <result pre="were compared with β-elemene for their proliferative activity in human" exact="leukemia" post="K562, gastric carcinoma SGC-7901, cervix epithelioid carcinoma HeLa cells."/>
  <result pre="β-elemenol have also displayed significant anticancer activities by the considerable" exact="suppression" post="in the non-small cell lung cancer cell proliferation. Among"/>
  <result pre="anticancer activities by the considerable suppression in the non-small cell" exact="lung cancer" post="cell proliferation. Among them, β-elemene enhanced cisplatin activity by"/>
  <result pre="activities by the considerable suppression in the non-small cell lung" exact="cancer" post="cell proliferation. Among them, β-elemene enhanced cisplatin activity by"/>
  <result pre="cell proliferation. Among them, β-elemene enhanced cisplatin activity by causing" exact="lung cancer" post="cell death, which was regulated by the CHK2-mediated cdc25C/cdc2/cyclin"/>
  <result pre="proliferation. Among them, β-elemene enhanced cisplatin activity by causing lung" exact="cancer" post="cell death, which was regulated by the CHK2-mediated cdc25C/cdc2/cyclin"/>
  <result pre="trioxide (ATO), synergistically enhances the antiproliferative activity and apoptosis of" exact="hepatocellular carcinoma" post="(HCC). It also downregulated Bcl-2 and pro-proteins of caspase"/>
  <result pre="various cancerous cells such as melanoma cells, glioblastoma cells, leukemia," exact="hepatocellular carcinoma" post="cells, human bladder cells, thyroid cells, ovarian cancer cells,"/>
  <result pre="cells, leukemia, hepatocellular carcinoma cells, human bladder cells, thyroid cells," exact="ovarian cancer" post="cells, and prostrate cells [ 69]. Recently, a research"/>
  <result pre="leukemia, hepatocellular carcinoma cells, human bladder cells, thyroid cells, ovarian" exact="cancer" post="cells, and prostrate cells [ 69]. Recently, a research"/>
  <result pre="that β-elemene can be a promising tool in doxorubicin resistant" exact="breast cancer" post="cells by altering the functionality and quantity of D-luciferin"/>
  <result pre="β-elemene can be a promising tool in doxorubicin resistant breast" exact="cancer" post="cells by altering the functionality and quantity of D-luciferin"/>
  <result pre="of non-curcuminoids possessing anti-cancer activities. It can alter and inhibit" exact="cancer" post="cells of various types, such as brain, lung, the"/>
  <result pre="alone or in combination to improve most chronic diseases like" exact="cancer" post="and revamp multidrug-resistant cancers. 4.2.2. δ-Elemene δ-Elemene is also"/>
  <result pre="caspase-3. It also exhibited promising behavior when treated for NCL-H292" exact="lung cancer" post="cells, as it showed apoptotic behavior in Hela cells"/>
  <result pre="It also exhibited promising behavior when treated for NCL-H292 lung" exact="cancer" post="cells, as it showed apoptotic behavior in Hela cells"/>
  <result pre="74]. Another study evaluated the effects of furanodiene on human" exact="leukemia" post="cell HL60 by DNA fragmentation and indicated that furanodiene"/>
  <result pre="cells. and explained that furanodiene is effective against uterine cervix" exact="cancer" post="(U14) cells and has a protective effect on immune"/>
  <result pre="dose-dependent manner caused cell death. This proved its efficacy on" exact="sarcoma" post="180 cells in mice and uterine cervical cancer growth"/>
  <result pre="its efficacy on sarcoma 180 cells in mice and uterine" exact="cervical cancer" post="growth [ 77]. Further, successful development and validation of"/>
  <result pre="efficacy on sarcoma 180 cells in mice and uterine cervical" exact="cancer" post="growth [ 77]. Further, successful development and validation of"/>
  <result pre="CDK2, pRb, total Rb, Bcl-Xl, and Akt. These expressions suppressed" exact="breast cancer" post="cell growth both in vitro and in vivo and"/>
  <result pre="pRb, total Rb, Bcl-Xl, and Akt. These expressions suppressed breast" exact="cancer" post="cell growth both in vitro and in vivo and"/>
  <result pre="the usefulness of furanodiene in combinational therapy to combat various" exact="cancer" post="cells. Xu et al. studied the antiproliferation activity of"/>
  <result pre="Xu et al. studied the antiproliferation activity of furanodiene on" exact="lung cancer" post="cells A549, NIH-H1299, and 95-D and studied its usefulness"/>
  <result pre="et al. studied the antiproliferation activity of furanodiene on lung" exact="cancer" post="cells A549, NIH-H1299, and 95-D and studied its usefulness"/>
  <result pre="they studied that furanodiene efficiently causes cell metastasis in 95-D" exact="lung cancer" post="cell, by activating the signaling molecules and regulating G1"/>
  <result pre="studied that furanodiene efficiently causes cell metastasis in 95-D lung" exact="cancer" post="cell, by activating the signaling molecules and regulating G1"/>
  <result pre="the combined effects of tamoxifen (TAM) and furanodiene in human" exact="breast cancer" post="cell in vitro. This research showed that the enhancement"/>
  <result pre="combined effects of tamoxifen (TAM) and furanodiene in human breast" exact="cancer" post="cell in vitro. This research showed that the enhancement"/>
  <result pre="via mitochondrial-caspase dependent, PARPg-independent and CDKs-cyclin signaling pathway in human" exact="breast cancer" post="cells without affecting the cytotoxicity of Tamoxifen [ 82]."/>
  <result pre="mitochondrial-caspase dependent, PARPg-independent and CDKs-cyclin signaling pathway in human breast" exact="cancer" post="cells without affecting the cytotoxicity of Tamoxifen [ 82]."/>
  <result pre="the cytotoxicity of Tamoxifen [ 82]. Furanodiene, when treated on" exact="breast cancer" post="cell lines MCF-7 and MDA-MB-231 suppressed proliferation and increased"/>
  <result pre="cytotoxicity of Tamoxifen [ 82]. Furanodiene, when treated on breast" exact="cancer" post="cell lines MCF-7 and MDA-MB-231 suppressed proliferation and increased"/>
  <result pre="G0/G1 phase. Furanodiene, when injected intraperitoneally in mice, witnessed tumor" exact="suppression" post="in a dose-dependent manner in vivo [ 83]. Zhong"/>
  <result pre="that furanodiene is a promising agent for treating chemo resistant" exact="breast cancer" post="cell. They studied that when doxorubicin-resistant breast cancer cells"/>
  <result pre="furanodiene is a promising agent for treating chemo resistant breast" exact="cancer" post="cell. They studied that when doxorubicin-resistant breast cancer cells"/>
  <result pre="chemo resistant breast cancer cell. They studied that when doxorubicin-resistant" exact="breast cancer" post="cells (MCF-7/DOXR) are treated with furanodiene, showed an alteration"/>
  <result pre="resistant breast cancer cell. They studied that when doxorubicin-resistant breast" exact="cancer" post="cells (MCF-7/DOXR) are treated with furanodiene, showed an alteration"/>
  <result pre="invasion, when taken in a non-toxic concentration, in highly metastatic" exact="breast cancer" post="MDA-MB-231 cell in vitro. This combination showed downregulation of"/>
  <result pre="when taken in a non-toxic concentration, in highly metastatic breast" exact="cancer" post="MDA-MB-231 cell in vitro. This combination showed downregulation of"/>
  <result pre="be used alone or in combination for different types of" exact="cancer" post="and drug resistant cancers. These extensive studies provide a"/>
  <result pre="to be established as a therapeutically effective natural compound for" exact="cancer" post="treatment. 4.4. Furanodienone Furanodienone is a sesquiterpene with a"/>
  <result pre="sesquiterpenoid that inhibits proliferation of Hela, OV-UL-2, MCF-7, and MM231" exact="cancer" post="cells by RNA synthesis in a concentration-dependent manner. It"/>
  <result pre="89]. Huang et al. revealed that curcumol brought apoptosis in" exact="nasopharyngeal carcinoma" post="CNE-2 cells by downregulation of NF-κB. This compound also"/>
  <result pre="when treated on hepatic stellate cells (HSC) induced apoptosis by" exact="suppression" post="of PI3K, Akt and Ikappa B. This suppression was"/>
  <result pre="apoptosis by suppression of PI3K, Akt and Ikappa B. This" exact="suppression" post="was due to the decrease in NF-κB and its"/>
  <result pre="91] ( Figure 3e). In addition, the anticancer effects on" exact="colorectal cancer" post="LOVO cells were enhanced by curcumol. This study showed"/>
  <result pre="( Figure 3e). In addition, the anticancer effects on colorectal" exact="cancer" post="LOVO cells were enhanced by curcumol. This study showed"/>
  <result pre="decreased Bcl-2 and increased Bax to induce apoptosis. Further, the" exact="suppression" post="of insulin-like factor-1 receptor (IGF-1R) escalated the phosphorylation of"/>
  <result pre="enone group [ 9]. They have shown inhibitory action on" exact="breast cancer" post="(MCF-7) cells [ 12]. Simon et al. investigated that"/>
  <result pre="group [ 9]. They have shown inhibitory action on breast" exact="cancer" post="(MCF-7) cells [ 12]. Simon et al. investigated that"/>
  <result pre="beneficial in combating numerous cancerous cells such as colon, gastric," exact="multiple myeloma," post="breast cells as well as multi-resistant cancer cells. A"/>
  <result pre="colon, gastric, multiple myeloma, breast cells as well as multi-resistant" exact="cancer" post="cells. A study of calebin A suggested that it"/>
  <result pre="A was found to be very effective for HCT-116 type" exact="colon cancer" post="cells and has proved to be more potent, when"/>
  <result pre="was found to be very effective for HCT-116 type colon" exact="cancer" post="cells and has proved to be more potent, when"/>
  <result pre="shift assay in vitro. This study showed that CA causes" exact="suppression" post="of receptor activator of nuclear factor kappa-B ligand (RANKL)-induced"/>
  <result pre="factor of activated T-cells cytoplasmic (NFATc–1), and cathepsin K. Additionally," exact="suppression" post="of phosphorylation, followed by the degradation of kB, NF-κB,"/>
  <result pre="of kB, NF-κB, which were the main source for the" exact="suppression" post="of osteoclastogenesis that induced multiple myeloma and breast cancer"/>
  <result pre="the main source for the suppression of osteoclastogenesis that induced" exact="multiple myeloma" post="and breast cancer [ 98]. Taken together, calebin A,"/>
  <result pre="for the suppression of osteoclastogenesis that induced multiple myeloma and" exact="breast cancer" post="[ 98]. Taken together, calebin A, alike curcumin exerts"/>
  <result pre="the suppression of osteoclastogenesis that induced multiple myeloma and breast" exact="cancer" post="[ 98]. Taken together, calebin A, alike curcumin exerts"/>
  <result pre="together, calebin A, alike curcumin exerts anticancer activities mainly on" exact="colon cancer" post="cells through induction of apoptosis and cell cycle arrest."/>
  <result pre="calebin A, alike curcumin exerts anticancer activities mainly on colon" exact="cancer" post="cells through induction of apoptosis and cell cycle arrest."/>
  <result pre="and cell cycle arrest. These compounds have positive results on" exact="breast cancer" post="cells and even on multi-resistant cancers. 4.8. Germacrone Germacrone,"/>
  <result pre="cell cycle arrest. These compounds have positive results on breast" exact="cancer" post="cells and even on multi-resistant cancers. 4.8. Germacrone Germacrone,"/>
  <result pre="cycle arrest and induction of apoptosis, brought about proliferation in" exact="breast cancer" post="cell in vitro. This demonstrated marked rise in LDH"/>
  <result pre="arrest and induction of apoptosis, brought about proliferation in breast" exact="cancer" post="cell in vitro. This demonstrated marked rise in LDH"/>
  <result pre="release and induction of depolarization of mitochondrial membrane potential in" exact="breast cancer" post="cells in a dose-dependent manner [ 99]. Bin et"/>
  <result pre="and induction of depolarization of mitochondrial membrane potential in breast" exact="cancer" post="cells in a dose-dependent manner [ 99]. Bin et"/>
  <result pre="Thus, these mechanisms proved germacrone as potent anticancer agent for" exact="liver cancer" post="[ 100] ( Figure 3G). The connectivity between germacrone"/>
  <result pre="these mechanisms proved germacrone as potent anticancer agent for liver" exact="cancer" post="[ 100] ( Figure 3G). The connectivity between germacrone"/>
  <result pre="apoptosis inHepG2 cells [ 101]. Anticancer activity of germacrone on" exact="breast cancer" post="cells was explained by Xie et al. They explained"/>
  <result pre="inHepG2 cells [ 101]. Anticancer activity of germacrone on breast" exact="cancer" post="cells was explained by Xie et al. They explained"/>
  <result pre="et al. They explained the aftermath of germacrone on human" exact="breast cancer" post="MCF-7/Adriamycin (ADR) MDR cells with the help of flow"/>
  <result pre="al. They explained the aftermath of germacrone on human breast" exact="cancer" post="MCF-7/Adriamycin (ADR) MDR cells with the help of flow"/>
  <result pre="5-fluorouracil and methotrexate, in elevating its antitumor activity, on positive" exact="breast cancer" post="cells estrogen receptor α (ER-α). These signals at transcriptional"/>
  <result pre="and methotrexate, in elevating its antitumor activity, on positive breast" exact="cancer" post="cells estrogen receptor α (ER-α). These signals at transcriptional"/>
  <result pre="carried out investigation to find an herbal remedy for its" exact="suppression" post="and found that Bisacurone in TNF-α activated by human"/>
  <result pre="carried to the nucleus, phosphorylation of inhibitory factor kBα and" exact="suppression" post="of ROS. Bisacurone, also showed inhibition of phosphorylation of"/>
  <result pre="turmeric and has been clinically used for the treatment of" exact="cervical cancer" post="in China. Prostaglandins are known to promote carcinogenic processes"/>
  <result pre="and has been clinically used for the treatment of cervical" exact="cancer" post="in China. Prostaglandins are known to promote carcinogenic processes"/>
  <result pre="manner [ 107]. Kong et al. studied MCF-7 and MDA-MB-231" exact="breast cancer" post="cell proliferation both alone, as well as in combination"/>
  <result pre="[ 107]. Kong et al. studied MCF-7 and MDA-MB-231 breast" exact="cancer" post="cell proliferation both alone, as well as in combination"/>
  <result pre="of germacrone and furanodiene [ 108]. Further, the inhibition of" exact="breast cancer" post="cell proliferation in nude xenograft mouse elucidated the anticancer"/>
  <result pre="germacrone and furanodiene [ 108]. Further, the inhibition of breast" exact="cancer" post="cell proliferation in nude xenograft mouse elucidated the anticancer"/>
  <result pre="when taken with other non-curcuminoids. Additionally, they work excellently on" exact="breast cancer" post="cells, which provide knowledge on their predominant anticancer potential."/>
  <result pre="taken with other non-curcuminoids. Additionally, they work excellently on breast" exact="cancer" post="cells, which provide knowledge on their predominant anticancer potential."/>
  <result pre="which concluded that the cell viability or proliferation decreased in" exact="cancer" post="cells especially lung cancer cells. Additionally, isobolographic assessment revealed"/>
  <result pre="the cell viability or proliferation decreased in cancer cells especially" exact="lung cancer" post="cells. Additionally, isobolographic assessment revealed that when total extract"/>
  <result pre="cell viability or proliferation decreased in cancer cells especially lung" exact="cancer" post="cells. Additionally, isobolographic assessment revealed that when total extract"/>
  <result pre="that curcumin is very efficient in treating various forms of" exact="cancer" post="such as colorectal, breast, head, and neck, pancreatic, and"/>
  <result pre="beneficial compound for medical purposes, mainly against numerous forms of" exact="cancer" post="including non-small cell lung cancer cell (NSCLC), liver, brain,"/>
  <result pre="purposes, mainly against numerous forms of cancer including non-small cell" exact="lung cancer" post="cell (NSCLC), liver, brain, esophageal squamous cell carcinoma, and"/>
  <result pre="mainly against numerous forms of cancer including non-small cell lung" exact="cancer" post="cell (NSCLC), liver, brain, esophageal squamous cell carcinoma, and"/>
  <result pre="into group of two for studying NSCLC and small cell" exact="lung cancer" post="(SCLC). Accelerated improvement in the survival and tumor response"/>
  <result pre="group of two for studying NSCLC and small cell lung" exact="cancer" post="(SCLC). Accelerated improvement in the survival and tumor response"/>
  <result pre="effects in patients treated with β-elemene injection as adjunctive for" exact="lung cancer" post="in contrast to patient given medication without β-elemene injection"/>
  <result pre="in patients treated with β-elemene injection as adjunctive for lung" exact="cancer" post="in contrast to patient given medication without β-elemene injection"/>
  <result pre="double-blind, randomized, two-dose, placebo-controlled and three-arm parallel study with 36" exact="rheumatoid arthritis" post="patients to examine the efficacy and safety of highly"/>
  <result pre="randomized, two-dose, placebo-controlled and three-arm parallel study with 36 rheumatoid" exact="arthritis" post="patients to examine the efficacy and safety of highly"/>
  <result pre="liposomal delivery system of β-elemene exhibiting anticancer activity, mainly on" exact="lung cancer" post="because of the various benefits such as availability, angiogenesis"/>
  <result pre="delivery system of β-elemene exhibiting anticancer activity, mainly on lung" exact="cancer" post="because of the various benefits such as availability, angiogenesis"/>
  <result pre="trials provided adequate evidence of β-elemene as a potent anti-lung" exact="cancer" post="agent. This also proved that the advancement in molecular"/>
  <result pre="optimistic drug delivery system for FN in the treatment of" exact="cancer" post="exhibiting high encapsulation efficiency and loading capacity. Even, through"/>
  <result pre="bioactivity of calebin A by enhancing its anticancer activity in" exact="colon cancer." post="This study explained that, besides enhanced solubility, liposomal calebin"/>
  <result pre="increased manner, establishing it as a promising agent in inhibiting" exact="colon cancer" post="(SW480) cells [ 125]. Therefore, these studies explain the"/>
  <result pre="manner, establishing it as a promising agent in inhibiting colon" exact="cancer" post="(SW480) cells [ 125]. Therefore, these studies explain the"/>
  <result pre="mitomycin [ 122]. Hence, these nanoparticles are promising in hepatoma" exact="cancer" post="to enhance the bioavailability of non-curcuminoids and improve their"/>
  <result pre="129]. The CNTM significantly improves the symptoms and biomarkers of" exact="rheumatoid arthritis" post="patients due to the anti-inflammatory properties of CNTM containing"/>
  <result pre="The CNTM significantly improves the symptoms and biomarkers of rheumatoid" exact="arthritis" post="patients due to the anti-inflammatory properties of CNTM containing"/>
  <result pre="kinase, cytokines and MMPs transcription factors as well as blocking" exact="cancer" post="cell proliferation at different phases of cell cycle such"/>
  <result pre="G2, M, S to induce apoptosis, are comparable to the" exact="cancer" post="fighting mechanism of curcuminoids. Further, modulation of p-glycoprotein in"/>
  <result pre="on varied catalogs such as by considering larger group of" exact="cancer" post="patients, extending treatment regimen duration and monitoring safe effective"/>
  <result pre="chemopreventive activities when used alone or in combination with other" exact="cancer" post="treatment drug can provide them as an epitome of"/>
  <result pre="Arsenic trioxide Bax Bcl 2-associated X protein Bcl B cell" exact="lymphoma" post="2 BCRP Breast cancer resistance protein Bid BH3-interacting domain"/>
  <result pre="2-associated X protein Bcl B cell lymphoma 2 BCRP Breast" exact="cancer" post="resistance protein Bid BH3-interacting domain death agonist BIP Binding"/>
  <result pre="of apoptosis protein IARC The international agency for research on" exact="cancer" post="IC50 Half-maximal inhibitory concentration IGF-1R Insulin-like factor-1 receptor IL2"/>
  <result pre="T-cells, cytoplasmic 1 NLC Nanostructured lipid carriers NSCLC Non-small cell" exact="lung cancer" post="cell N-WASP Neural Wiskott-Aldrich syndrome protein PARP Poly (ADP-ribose)"/>
  <result pre="cytoplasmic 1 NLC Nanostructured lipid carriers NSCLC Non-small cell lung" exact="cancer" post="cell N-WASP Neural Wiskott-Aldrich syndrome protein PARP Poly (ADP-ribose)"/>
  <result pre="and anticancer activity of curcuma: A potential chemopreventive strategy against" exact="hepatocellular carcinoma" post="Int. J. Oncol. 2014 44 505 513 10.3892/ijo.2013.2184 24270742"/>
  <result pre="through reactive oxygen species-triggered intrinsic and extrinsic pathways in human" exact="hepatocellular carcinoma" post="HepG2 cells J. Agric. Food Chem. 2012 60 9620"/>
  <result pre="internucleosomal DNA fragmentation associated with programmed cell death in human" exact="myeloid leukemia" post="HL-60 cells Arch. Pharm. Res. 1996 19 91 94"/>
  <result pre="DNA fragmentation associated with programmed cell death in human myeloid" exact="leukemia" post="HL-60 cells Arch. Pharm. Res. 1996 19 91 94"/>
  <result pre="south Indian black turmeric ( Curcuma caesia Roxb.) to target" exact="cancer" post="apoptosis J. Ethnopharmacol. 2017 209 82 90 10.1016/j.jep.2017.07.021 28733192"/>
  <result pre="Reed E. Li Q.Q. Antitumor effect of β-elemene in non-small-cell" exact="lung cancer" post="cells is mediated via induction of cell cycle arrest"/>
  <result pre="E. Li Q.Q. Antitumor effect of β-elemene in non-small-cell lung" exact="cancer" post="cells is mediated via induction of cell cycle arrest"/>
  <result pre="induces apoptosis as well as protective autophagy in human non-small-cell" exact="lung cancer" post="A549 cells J. Pharm. pharmacol. 2011 64 146 153"/>
  <result pre="apoptosis as well as protective autophagy in human non-small-cell lung" exact="cancer" post="A549 cells J. Pharm. pharmacol. 2011 64 146 153"/>
  <result pre="and ERK signals are involved in β-elemene-induced cell apoptosis in" exact="lung cancer" post="cells Mol. Med. Rep. 2011 4 1243 1246 21837364"/>
  <result pre="ERK signals are involved in β-elemene-induced cell apoptosis in lung" exact="cancer" post="cells Mol. Med. Rep. 2011 4 1243 1246 21837364"/>
  <result pre="through activation of ERK1/2 and AMPKa signalling pathways in human" exact="lung cancer" post="cells: The role of Sp1 J. Cell. Mol. Med."/>
  <result pre="activation of ERK1/2 and AMPKa signalling pathways in human lung" exact="cancer" post="cells: The role of Sp1 J. Cell. Mol. Med."/>
  <result pre="induction of cell apoptosis and cell cycle arresting non-small cell" exact="lung carcinoma" post="cells Mol. Med. Rep. 2011 4 1189 1193 21904777"/>
  <result pre="Li L. Che X.M. Anticancer effects of β-elemene in gastric" exact="cancer" post="cells and its potential underlying proteins: A proteomic study"/>
  <result pre="Ren S. Zuo Y. Antitumor effect of β-elemene in murine" exact="hepatocellular carcinoma" post="cell line H22 depends on the level of c-Met"/>
  <result pre="β-elemene and taxanes synergistically induce cytotoxicity and inhibit proliferation in" exact="ovarian cancer" post="and other tumor cells Anticancer Res. 2013 33 929"/>
  <result pre="and taxanes synergistically induce cytotoxicity and inhibit proliferation in ovarian" exact="cancer" post="and other tumor cells Anticancer Res. 2013 33 929"/>
  <result pre="Huang F. Li J.M. Cuff C.F. Reed E. Sensitization of" exact="lung cancer" post="cells to cisplatin by b-elemene is mediated through blockade"/>
  <result pre="F. Li J.M. Cuff C.F. Reed E. Sensitization of lung" exact="cancer" post="cells to cisplatin by b-elemene is mediated through blockade"/>
  <result pre="and causes apoptosis via the ROS/MAPKs-mediated caspase-dependent pathway in human" exact="colorectal cancer" post="cells: A study in vitro and in vivo Cell"/>
  <result pre="causes apoptosis via the ROS/MAPKs-mediated caspase-dependent pathway in human colorectal" exact="cancer" post="cells: A study in vitro and in vivo Cell"/>
  <result pre="intracellular transport of d-luciferin potassium salt (ABC substrate) in doxorubicin-resistant" exact="breast cancer" post="cells and the associated molecular mechanism Eur. J. Pharm."/>
  <result pre="transport of d-luciferin potassium salt (ABC substrate) in doxorubicin-resistant breast" exact="cancer" post="cells and the associated molecular mechanism Eur. J. Pharm."/>
  <result pre="and apoptosis through MAPK signaling and mitochondria-caspase pathway in human" exact="hepatocellular carcinoma" post="cells Cancer Biol. Ther. 2007 6 1044 1050 10.4161/cbt.6.7.4317"/>
  <result pre="T. Guo T. Induction of apoptosis by furanodiene in HL60" exact="leukemia" post="cells through activation of TNFR1 signaling pathway Cancer Lett."/>
  <result pre="Q. Chena X. et al. Furanodiene, a natural product, inhibits" exact="breast cancer" post="growth both in vitro and in vivo Cell. Physiol."/>
  <result pre="Chena X. et al. Furanodiene, a natural product, inhibits breast" exact="cancer" post="growth both in vitro and in vivo Cell. Physiol."/>
  <result pre="Furanodiene induces endoplasmic reticulum stress and presents antiproliferative activities in" exact="lung cancer" post="cells Evid. Based Complement. Altern. Med. 2012 2012 426521"/>
  <result pre="induces endoplasmic reticulum stress and presents antiproliferative activities in lung" exact="cancer" post="cells Evid. Based Complement. Altern. Med. 2012 2012 426521"/>
  <result pre="Wang Y.T. Furanodiene enhances tamoxifen-induced growth inhibitory activity of ERa-positive" exact="breast cancer" post="cells in a PPARg independent manner J. Cell. Biochem."/>
  <result pre="Y.T. Furanodiene enhances tamoxifen-induced growth inhibitory activity of ERa-positive breast" exact="cancer" post="cells in a PPARg independent manner J. Cell. Biochem."/>
  <result pre="X. Wang Y. Furanodiene, a natural small molecule suppresses metastatic" exact="breast cancer" post="cell migration and invasion in vitro Eur. J. Pharm."/>
  <result pre="Wang Y. Furanodiene, a natural small molecule suppresses metastatic breast" exact="cancer" post="cell migration and invasion in vitro Eur. J. Pharm."/>
  <result pre="Wang Y.T. Furanodiene alters mitochondrial function in doxorubicin-resistant MCF-7 human" exact="breast cancer" post="cells in an AMPK-dependent manner Mol. Biosyst. 2016 12"/>
  <result pre="Y.T. Furanodiene alters mitochondrial function in doxorubicin-resistant MCF-7 human breast" exact="cancer" post="cells in an AMPK-dependent manner Mol. Biosyst. 2016 12"/>
  <result pre="furanodiene and doxorubicin on the migration and invasion of MDA-MB-231" exact="breast cancer" post="cells in vitro Oncol. Rep. 2016 37 2016 2024"/>
  <result pre="and doxorubicin on the migration and invasion of MDA-MB-231 breast" exact="cancer" post="cells in vitro Oncol. Rep. 2016 37 2016 2024"/>
  <result pre="cell proliferation and survival by suppressing ERα signaling in human" exact="breast cancer" post="MCF-7 cells J. Cell. Biochem. 2011 112 217 224"/>
  <result pre="proliferation and survival by suppressing ERα signaling in human breast" exact="cancer" post="MCF-7 cells J. Cell. Biochem. 2011 112 217 224"/>
  <result pre="arrest and apoptosis by suppressing EGFR/HER2 signaling in HER2-overexpressing human" exact="breast cancer" post="cells Cancer Chemother. Pharmacol. 2011 68 1315 1323 10.1007/s00280-011-1624-x"/>
  <result pre="and apoptosis by suppressing EGFR/HER2 signaling in HER2-overexpressing human breast" exact="cancer" post="cells Cancer Chemother. Pharmacol. 2011 68 1315 1323 10.1007/s00280-011-1624-x"/>
  <result pre="Loganathachetti D.S. Nainangu P. Chen B. β-Elemene: Mechanistic studies on" exact="cancer" post="cell interaction and its chemosensitization effect, Mini review Front."/>
  <result pre="Hong B. Niu Y. Curcumol induces HSC-T6 cell death through" exact="suppression" post="of Bcl-2: Involvement of PI3K and NF-κB pathways Eur."/>
  <result pre="apoptosis and modulates MAPK family activity in drug resistant human" exact="cancer" post="cell Eur. J. Pharmacol. 2008 591 252 258 10.1016/j.ejphar.2008.06.065"/>
  <result pre="Lee P.S. Calebin A induces cell cycle arrest in human" exact="colon cancer" post="cells and xenografts in nude mice J. Funct. Foods"/>
  <result pre="P.S. Calebin A induces cell cycle arrest in human colon" exact="cancer" post="cells and xenografts in nude mice J. Funct. Foods"/>
  <result pre="S. Majeed M. Aggarwal B.B. Calebin A downregulates osteoclastogenesis through" exact="suppression" post="of RANKL signaling Arch. Biochem. Biophys. 2016 593 80"/>
  <result pre="T. Cui L. Wang Y. Germacrone inhibits the proliferation of" exact="breast cancer" post="cell lines by inducing cell cycle arrest and promoting"/>
  <result pre="Cui L. Wang Y. Germacrone inhibits the proliferation of breast" exact="cancer" post="cell lines by inducing cell cycle arrest and promoting"/>
  <result pre="X.D. Germacrone reverses adriamycin resistance through cell apoptosis in multidrug-resistant" exact="breast cancer" post="cells Exp. Ther. Med. 2014 8 1611 1615 10.3892/etm.2014.1932"/>
  <result pre="Germacrone reverses adriamycin resistance through cell apoptosis in multidrug-resistant breast" exact="cancer" post="cells Exp. Ther. Med. 2014 8 1611 1615 10.3892/etm.2014.1932"/>
  <result pre="Jeong K.W. Germacrone inhibits estrogen receptor α-mediated transcription in MCF-7" exact="breast cancer" post="cells Phytother. Res. 2016 30 2036 2043 10.1002/ptr.5711 27573551"/>
  <result pre="K.W. Germacrone inhibits estrogen receptor α-mediated transcription in MCF-7 breast" exact="cancer" post="cells Phytother. Res. 2016 30 2036 2043 10.1002/ptr.5711 27573551"/>
  <result pre="K.C. et al. Bisacurone inhibits adhesion of inflammatory monocytes or" exact="cancer" post="cells to endothelial cells through down-regulation of VCAM-1 expression"/>
  <result pre="Impact of Fixed-Dose Combination of germacrone, curdione, and furanodiene on" exact="breast cancer" post="cell proliferation Cell J. 2013 15 160 165 23862118"/>
  <result pre="of Fixed-Dose Combination of germacrone, curdione, and furanodiene on breast" exact="cancer" post="cell proliferation Cell J. 2013 15 160 165 23862118"/>
  <result pre="T. Systematic Review of β-Elemene injection as adjunctive treatment for" exact="lung cancer" post="Chin. J. Integr. Med. 2012 18 813 823 10.1007/s11655-012-1271-9"/>
  <result pre="Systematic Review of β-Elemene injection as adjunctive treatment for lung" exact="cancer" post="Chin. J. Integr. Med. 2012 18 813 823 10.1007/s11655-012-1271-9"/>
  <result pre="highly bioavailable curcumin formulation improves symptoms and diagnostic indicators in" exact="rheumatoid arthritis" post="patients: A randomized, double-blind, placebo-controlled, two-dose, three-arm, and parallel-group"/>
  <result pre="bioavailable curcumin formulation improves symptoms and diagnostic indicators in rheumatoid" exact="arthritis" post="patients: A randomized, double-blind, placebo-controlled, two-dose, three-arm, and parallel-group"/>
  <result pre="triphosphate; Bax, Bcl 2 associated X protein; Bcl, B cell" exact="lymphoma" post="2; cdc, cell division cycle; CDKI, cyclin–dependent kinases inhibitors;"/>
  <result pre="B (PI3K/Akt) and extracellular regulated kinase (ERK)1/2 signaling in human" exact="breast cancer" post="cells and inhibited TPA induced invasion, migration, and colony"/>
  <result pre="(PI3K/Akt) and extracellular regulated kinase (ERK)1/2 signaling in human breast" exact="cancer" post="cells and inhibited TPA induced invasion, migration, and colony"/>
  <result pre="inhibited TPA induced invasion, migration, and colony formation in human" exact="breast cancer" post="cells. [ 36] Ar-turmerone was effective on murine dendritic"/>
  <result pre="TPA induced invasion, migration, and colony formation in human breast" exact="cancer" post="cells. [ 36] Ar-turmerone was effective on murine dendritic"/>
  <result pre="dendritic cells (DCs). [ 37] Ar-turmerone showed inhibitory action against" exact="hepatocellular carcinoma" post="cells by apoptosis through intracellular reactive oxygen species (ROS)"/>
  <result pre="(JNK) kinases. [ 38] Ar-turmerone had cytotoxic effects on Lymphocytic" exact="leukemia" post="(L-1210) and myeloid cell line (HL-60) cells with an"/>
  <result pre="Ar-turmerone, when motif-fused with spiropyrollidone oxindoles increased the potency in" exact="lung cancer" post="and leukemia cells. [ 41] Ar-turmerone and its analogs"/>
  <result pre="when motif-fused with spiropyrollidone oxindoles increased the potency in lung" exact="cancer" post="and leukemia cells. [ 41] Ar-turmerone and its analogs"/>
  <result pre="with spiropyrollidone oxindoles increased the potency in lung cancer and" exact="leukemia" post="cells. [ 41] Ar-turmerone and its analogs exhibited cytotoxic"/>
  <result pre="in morphological characters. [ 43] Ar-turmerone exhibited apoptosis on human" exact="myeloid leukemia" post="HL-60 cells. [ 44] Elemene Elemene can inhibit the"/>
  <result pre="morphological characters. [ 43] Ar-turmerone exhibited apoptosis on human myeloid" exact="leukemia" post="HL-60 cells. [ 44] Elemene Elemene can inhibit the"/>
  <result pre="47] β-elemene The mechanism of action of β-elemene in non-small-cell" exact="lung cancer" post="cell (NSCLC) death may be through a mitochondrial release"/>
  <result pre="β-elemene The mechanism of action of β-elemene in non-small-cell lung" exact="cancer" post="cell (NSCLC) death may be through a mitochondrial release"/>
  <result pre="inhibited ERK and Akt activation and upregulation of Casitas B–lineage" exact="lymphoma" post="(c-Cb1 and Cb1-b) expression to initiate apoptosis in lung"/>
  <result pre="B–lineage lymphoma (c-Cb1 and Cb1-b) expression to initiate apoptosis in" exact="lung cancer" post="cells. [ 51] β-elemene has potential to inhibit human"/>
  <result pre="lymphoma (c-Cb1 and Cb1-b) expression to initiate apoptosis in lung" exact="cancer" post="cells. [ 51] β-elemene has potential to inhibit human"/>
  <result pre="cancer cells. [ 51] β-elemene has potential to inhibit human" exact="lung cancer" post="NSCLC cell growth via ERK1/2- and AMP-activated protein kinase"/>
  <result pre="cells. [ 51] β-elemene has potential to inhibit human lung" exact="cancer" post="NSCLC cell growth via ERK1/2- and AMP-activated protein kinase"/>
  <result pre="[ 52] β-elemene in combination with etoposide is beneficial for" exact="lung cancer" post="cells. [ 53] β-elemene is a promising therapeutic role"/>
  <result pre="52] β-elemene in combination with etoposide is beneficial for lung" exact="cancer" post="cells. [ 53] β-elemene is a promising therapeutic role"/>
  <result pre="a promising therapeutic role in human SGC7901 and MKN45 gastric" exact="cancer" post="cells. [ 54] β-elemene and its relation between the"/>
  <result pre="inhibited the proliferation and survival of the cell lines of" exact="glioblastoma multiforme" post="(GBM) when combined with radiotherapy or temozolomide (TMZ) via"/>
  <result pre="activated protein kinase 3/6/p38 and extracellular signal-regulated kinase 1/2/B cell" exact="lymphoma" post="2/surviving pathways. [ 61] β-elemene enhances susceptibility to cisplatin"/>
  <result pre="2/surviving pathways. [ 61] β-elemene enhances susceptibility to cisplatin resistant" exact="ovarian cancer" post="cell. [ 12] β-elemene exhibited antiproliferative activities, promoted apoptosis,"/>
  <result pre="pathways. [ 61] β-elemene enhances susceptibility to cisplatin resistant ovarian" exact="cancer" post="cell. [ 12] β-elemene exhibited antiproliferative activities, promoted apoptosis,"/>
  <result pre="in human cervix epitheloid carcinoma HeLa, gastric carcinoma SGC-7901, and" exact="leukemia" post="K562 cells. [ 63] β elemene monosubstituted amine, ether"/>
  <result pre="were promising. [ 64] β-elemene-enhanced inhibitory effect of cisplatin on" exact="lung carcinoma" post="cell proliferation, regulated by a check point kinase (CHK)"/>
  <result pre="ester (ETME) synergistically enhanced the antiproliferative activity and apoptosis in" exact="hepatocellular carcinoma" post="(HCC) cells. [ 66] Novel furoxan-based NO- donating β-elemene"/>
  <result pre="68] β-elemene was reviewed for its anticancer effects on different" exact="cancer" post="cells and apoptosis and cell cycle arrest were found"/>
  <result pre="and quantity of ABC transporters thereby efficient in doxorubicin resistant" exact="breast cancer" post="cells. [ 69, 70] The possible mode of anticancer"/>
  <result pre="quantity of ABC transporters thereby efficient in doxorubicin resistant breast" exact="cancer" post="cells. [ 69, 70] The possible mode of anticancer"/>
  <result pre="levels were seen when δ -elemene was treated in NCL-H292" exact="lung cancer" post="cells through activation of the caspase signaling pathway. ["/>
  <result pre="were seen when δ -elemene was treated in NCL-H292 lung" exact="cancer" post="cells through activation of the caspase signaling pathway. ["/>
  <result pre="of liver diseases. [ 74] Furanodiene was influential on human" exact="leukemia" post="HL60 cells, evaluated by DNA fragmentation. [ 75] Furanodiene"/>
  <result pre="bromide) tetrazolium reduction assay MTT assay, thus effective against uterine" exact="cervical cancer" post="growth. [ 77] Bioavailability of furanodiene in rat’s plasma"/>
  <result pre="tetrazolium reduction assay MTT assay, thus effective against uterine cervical" exact="cancer" post="growth. [ 77] Bioavailability of furanodiene in rat’s plasma"/>
  <result pre="chromatography/tandem mass spectrometry was about 49.0%. [ 78] Furanodiene suppresses" exact="breast cancer" post="cell growth both in vitro and in vivo in"/>
  <result pre="mass spectrometry was about 49.0%. [ 78] Furanodiene suppresses breast" exact="cancer" post="cell growth both in vitro and in vivo in"/>
  <result pre="and apoptosis nature of tamoxifen, thus facilitating the treatment of" exact="breast cancer." post="It was beneficial against proliferation carried out by vascular"/>
  <result pre="80] Furanodiene showed antiproliferative activity on A549, NIH-H1299, and 95-D" exact="lung cancer" post="cells and was useful in combination therapy with paclitaxel."/>
  <result pre="Furanodiene showed antiproliferative activity on A549, NIH-H1299, and 95-D lung" exact="cancer" post="cells and was useful in combination therapy with paclitaxel."/>
  <result pre="and apoptosis in breast cells. [ 83] Doxorubicin-resistant MCF-7 (MCF-7/DOXR)" exact="breast cancer" post="cells, when treated with furanodiene showed an alteration in"/>
  <result pre="apoptosis in breast cells. [ 83] Doxorubicin-resistant MCF-7 (MCF-7/DOXR) breast" exact="cancer" post="cells, when treated with furanodiene showed an alteration in"/>
  <result pre="[ 84] The combinational treatment of furanodiene with doxorubicin in" exact="breast cancer" post="cells were found promising. [ 85] Furanodienone Furanodienone inhibited"/>
  <result pre="84] The combinational treatment of furanodiene with doxorubicin in breast" exact="cancer" post="cells were found promising. [ 85] Furanodienone Furanodienone inhibited"/>
  <result pre="(ER) beta. [ 86] Furanodienone also triggered apoptosis on human" exact="breast cancer" post="cells through epithelial growth factor pathways. [ 87] Furanodienone"/>
  <result pre="beta. [ 86] Furanodienone also triggered apoptosis on human breast" exact="cancer" post="cells through epithelial growth factor pathways. [ 87] Furanodienone"/>
  <result pre="cell proliferation by RNA synthesis in a concentration-dependent manner in" exact="lung cancer." post="[ 89] Curcumol bring apoptosis in nasopharyngeal carcinoma CNE-2"/>
  <result pre="manner in lung cancer. [ 89] Curcumol bring apoptosis in" exact="nasopharyngeal carcinoma" post="CNE-2 cells by down regulation of NF-kb. [ 90]"/>
  <result pre="down regulation of NF-kb. [ 90] Curcumol induced apoptosis by" exact="suppression" post="of PI3K/Nf-kB pathway on hepatic stellate cells. [ 91]"/>
  <result pre="[ 91] Curcumol exhibited promising anticancer effects when treated on" exact="colorectal cancer" post="cells (LOVO). [ 92] Cyclocurcumin Cyclocurcumin inhibited the proliferation"/>
  <result pre="91] Curcumol exhibited promising anticancer effects when treated on colorectal" exact="cancer" post="cells (LOVO). [ 92] Cyclocurcumin Cyclocurcumin inhibited the proliferation"/>
  <result pre="cells (LOVO). [ 92] Cyclocurcumin Cyclocurcumin inhibited the proliferation of" exact="breast cancer" post="cells. [ 12] When combined with curcumin, cyclocurcumin showed"/>
  <result pre="(LOVO). [ 92] Cyclocurcumin Cyclocurcumin inhibited the proliferation of breast" exact="cancer" post="cells. [ 12] When combined with curcumin, cyclocurcumin showed"/>
  <result pre="A inhibited growth and induced apoptosis in drug-resistant human gastric" exact="cancer" post="cells reduction in S phase and G2/M phase arrest."/>
  <result pre="arrest. [ 96] Calebin A inhibited growth in drug-resistant human" exact="colon cancer" post="cells by decreasing the expression of cell cycle regulatory"/>
  <result pre="[ 96] Calebin A inhibited growth in drug-resistant human colon" exact="cancer" post="cells by decreasing the expression of cell cycle regulatory"/>
  <result pre="inducing apoptosis. [ 97] Calebin A has wide scope in" exact="multiple myeloma" post="and breast cancer cells by suppression of osteoclastogenesis. ["/>
  <result pre="97] Calebin A has wide scope in multiple myeloma and" exact="breast cancer" post="cells by suppression of osteoclastogenesis. [ 98] Germacrone Germacrone"/>
  <result pre="Calebin A has wide scope in multiple myeloma and breast" exact="cancer" post="cells by suppression of osteoclastogenesis. [ 98] Germacrone Germacrone"/>
  <result pre="wide scope in multiple myeloma and breast cancer cells by" exact="suppression" post="of osteoclastogenesis. [ 98] Germacrone Germacrone inhibited human breast"/>
  <result pre="by suppression of osteoclastogenesis. [ 98] Germacrone Germacrone inhibited human" exact="breast cancer" post="cells by cell cycle arrest and apoptosis with increase"/>
  <result pre="suppression of osteoclastogenesis. [ 98] Germacrone Germacrone inhibited human breast" exact="cancer" post="cells by cell cycle arrest and apoptosis with increase"/>
  <result pre="anti- tumor activity of methotrexate and 5-fluorouracil on ER α-positive" exact="breast cancer" post="cells. [ 103] The derivatives of germacrone had inhibitory"/>
  <result pre="tumor activity of methotrexate and 5-fluorouracil on ER α-positive breast" exact="cancer" post="cells. [ 103] The derivatives of germacrone had inhibitory"/>
  <result pre="molecular docking study [ 105] Bisacurone Bisacurone inhibits adhesion of" exact="cancer" post="cells to endothelial cells through down regulation of vascular"/>
  <result pre="(PG), E2 in lipopolysaccharide (LPS)-stimulated mouse machrophages RAW 264.7 through" exact="suppression" post="of enzyme COX-2 mRNA expression in a dose-dependent manner."/>
  <result pre="(germacrone, curdione, furanodiene) had proliferative activity on MDA-MB-231 and MCF-7" exact="breast cancer" post="cells, alone or in combination with a fixed-dose-combination. ["/>
  <result pre="curdione, furanodiene) had proliferative activity on MDA-MB-231 and MCF-7 breast" exact="cancer" post="cells, alone or in combination with a fixed-dose-combination. ["/>
  <result pre="with a fixed-dose-combination. [ 108] Curdione inhibited the proliferation of" exact="breast cancer" post="cells in xenograft nude mouse in a dose-dependent manner."/>
  <result pre="a fixed-dose-combination. [ 108] Curdione inhibited the proliferation of breast" exact="cancer" post="cells in xenograft nude mouse in a dose-dependent manner."/>
  <result pre="kinase; ER, estrogen receptor; ETME, N-(β-elemene-13-yl) tryptophan methyl ester; HCC," exact="hepatocellular carcinoma;" post="GBM, glioblastoma multiforme; HCC, hepatocellular carcinoma; HCT, human colon"/>
  <result pre="receptor; ETME, N-(β-elemene-13-yl) tryptophan methyl ester; HCC, hepatocellular carcinoma; GBM," exact="glioblastoma multiforme;" post="HCC, hepatocellular carcinoma; HCT, human colon carcinoma; HL-60, myeloid"/>
  <result pre="tryptophan methyl ester; HCC, hepatocellular carcinoma; GBM, glioblastoma multiforme; HCC," exact="hepatocellular carcinoma;" post="HCT, human colon carcinoma; HL-60, myeloid cell line; HT,"/>
  <result pre="kinase; L1210, lymphocytic leukemia; LDH, lactate dehydrogenase; LPS, lipopolysaccharide; LOVO," exact="colorectal cancer" post="cell; Lr-1, [(R or S)–2–((1R,3S,4S)–3–isopropenyl–4–methyl–4–vinylcyclohexyl)–propane–1,2–diol]; Lr-2- [(S)–2–((1R,3S,4S)–3–isopropenyl–4–methyl–4–vinyl–cyclohexyl)–propane–1,2–diol and (R)–2–((1R,3S,4S)–3–isopropenyl–4–methyl–4–vinylcyclohexyl)–propane–1,2–diol];"/>
  <result pre="L1210, lymphocytic leukemia; LDH, lactate dehydrogenase; LPS, lipopolysaccharide; LOVO, colorectal" exact="cancer" post="cell; Lr-1, [(R or S)–2–((1R,3S,4S)–3–isopropenyl–4–methyl–4–vinylcyclohexyl)–propane–1,2–diol]; Lr-2- [(S)–2–((1R,3S,4S)–3–isopropenyl–4–methyl–4–vinyl–cyclohexyl)–propane–1,2–diol and (R)–2–((1R,3S,4S)–3–isopropenyl–4–methyl–4–vinylcyclohexyl)–propane–1,2–diol];"/>
  <result pre="rapamycin; MTT assay, (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) tetrazolium reduction assay; NCL-H292, mucoepidermoid" exact="lung cancer" post="cell; NF-kB, nuclear factor kappa light chain enhancer of"/>
  <result pre="MTT assay, (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) tetrazolium reduction assay; NCL-H292, mucoepidermoid lung" exact="cancer" post="cell; NF-kB, nuclear factor kappa light chain enhancer of"/>
  <result pre="light chain enhancer of activated B cells; NSCLC, non-small cell" exact="lung cancer" post="cell; P-gp (MDRI gene) mRNA, permeability glycoprotein multidrug resistant"/>
  <result pre="chain enhancer of activated B cells; NSCLC, non-small cell lung" exact="cancer" post="cell; P-gp (MDRI gene) mRNA, permeability glycoprotein multidrug resistant"/>
  <result pre="β-elemene Anticancer agent for lung, breast, gastrointestinal, skin and gynecological" exact="cancer" post="cells [ 122] Phase inversion method β-elemene Anticancer agent"/>
  <result pre="Phase inversion method β-elemene Anticancer agent for hepatoma 3B cells" exact="cancer" post="cells [ 127] PNS Cureit Polar-nonpolar-sandwich (PNS) technology Complete"/>
 </snippets>
</snippetsTree>
